Abstract
Cognitive impairment is common in Parkinson's disease (PD), and many patients will eventually develop a dementia, which has a devastating impact on the patient and their family. As such, there has been much interest in identifying a prodromal state to inform prognosis and facilitate earlier management, similar to the concept of 'MCI' in the Alzheimer's field. However, grouping the early cognitive deficits of PD together as 'PD-MCI' may not be the best way forward as it implies a single aetiological basis with one clinical consequence. In this review, we argue that cognitive deficits in PD arise from a number of different pathological pathways, only some of which herald a dementing process. This has important implications both for treatment of individual patients, and for the design of future disease-modifying therapy trials.
| Original language | English |
|---|---|
| Pages (from-to) | 651-6 |
| Number of pages | 6 |
| Journal | Journal of Parkinson's Disease |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2014 |
Free keywords
- Humans
- Mild Cognitive Impairment
- Neuropsychological Tests
- Parkinson Disease
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
Fingerprint
Dive into the research topics of 'Mild cognitive impairment and Parkinson's disease - something to remember'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver